Literature DB >> 19871072

THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : III. IMMUNOLOGICAL PROPERTIES OF THE C-REACTIVE PROTEIN AND ITS DIFFERENTIATION FROM NORMAL BLOOD PROTEINS.

C M Macleod1, O T Avery.   

Abstract

The C-reactive protein present in the albumin fraction of the serum of patients during certain acute bacterial infections is highly antigenic upon injection into rabbits. The antiserum thus prepared reacts specifically with this protein and does not react with the proteins of normal human serum. Immunological specificity has been demonstrated by both precipitin and complement-fixation tests. Antiserum prepared in rabbits to the C-reactive protein from human sources also reacts specifically with the similar protein in the serum of monkeys acutely ill with experimental pneumococcus infection. By means of immunological reactions it is possible to detect amounts of reactive protein which are too small to yield a visible precipitate in tests with the C polysaccharide. Certain of the properties are discussed which distinguish the C-reactive protein from the proteins of normal human serum.

Entities:  

Year:  1941        PMID: 19871072      PMCID: PMC2135125          DOI: 10.1084/jem.73.2.191

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS.

Authors:  W S Tillett; T Francis
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

2.  IMMUNOLOGICAL STUDIES OF A HEAT-STABLE SUBSTANCE ISOLATED FROM TISSUES INFECTED WITH VACCINE VIRUS.

Authors:  R F Parker
Journal:  J Exp Med       Date:  1938-02-28       Impact factor: 14.307

3.  IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : VI. ISOLATION OF A HEAT-STABLE, SEROLOGICALLY ACTIVE SUBSTANCE FROM TISSUES INFECTED WITH VACCINE VIRUS.

Authors:  R F Parker; T M Rivers
Journal:  J Exp Med       Date:  1937-01-31       Impact factor: 14.307

4.  INFECTIOUS MYXOMATOSIS OF RABBITS : PREPARATION OF ELEMENTARY BODIES AND STUDIES OF SEROLOGICALLY ACTIVE MATERIALS ASSOCIATED WITH THE DISEASE.

Authors:  T M Rivers; S M Ward
Journal:  J Exp Med       Date:  1937-06-30       Impact factor: 14.307

5.  INFECTIOUS MYXOMATOSIS OF RABBITS : II. DEMONSTRATION OF A SECOND SOLUBLE ANTIGEN ASSOCIATED WITH THE DISEASE.

Authors:  J E Smadel; S M Ward; T M Rivers
Journal:  J Exp Med       Date:  1940-07-31       Impact factor: 14.307

6.  SPECIFIC AND NON-SPECIFIC POLYSACCHARIDES OF TYPE IV PNEUMOCOCCUS.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1931-04-30       Impact factor: 14.307

7.  A SOLUBLE ANTIGEN OF LYMPHOCYTIC CHORIOMENINGITIS : II. INDEPENDENCE OF ANTI-SOLUBLE SUBSTANCE ANTIBODIES AND NEUTRALIZING ANTIBODIES, AND THE ROLE OF SOLUBLE ANTIGEN AND INACTIVE VIRUS IN IMMUNITY TO INFECTION.

Authors:  J E Smadel; M J Wall
Journal:  J Exp Med       Date:  1940-09-30       Impact factor: 14.307

8.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : II. ISOLATION AND PROPERTIES OF THE REACTIVE PROTEIN.

Authors:  C M Macleod; O T Avery
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

9.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : I. DISTRIBUTION OF THE REACTIVE PROTEIN IN PATIENTS' SERA AND THE EFFECT OF CALCIUM ON THE FLOCCULATION REACTION WITH C POLYSACCHARIDE OF PNEUMOCOCCUS.

Authors:  T J Abernethy; O T Avery
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

10.  CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF A SPECIES-SPECIFIC CARBOHYDRATE OF PNEUMOCOCCI.

Authors:  W S Tillett; W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1930-11-30       Impact factor: 14.307

View more
  22 in total

1.  [Early diagnosis of post-operative complications with the aid of C-reactive proteins].

Authors:  H BALDAUF; W JACOBY
Journal:  Acta Neurochir (Wien)       Date:  1959       Impact factor: 2.216

2.  [Gamma-x-globulin, an immunoelectrophoretic demonstrable gamma-globulin-component with relations to C-reactive protein].

Authors:  H E SCHULTZE; G SCHWICK; J SONNET; J HEREMANS; J L MICHAUX
Journal:  Klin Wochenschr       Date:  1960-01-15

3.  [Quantitative determination of C-reactive proteins].

Authors:  J ZACH
Journal:  Klin Wochenschr       Date:  1957-09-15

4.  [Clinical studies on acute phase protein (C-reactive protein)].

Authors:  H BAUER; D SEITZ
Journal:  Klin Wochenschr       Date:  1953-04-01

5.  [Demonstration of the C-reactive protein in normal serums].

Authors:  F Scheiffarth; M Pérez-Miranda; H Götz
Journal:  Blut       Date:  1970-05

6.  The C-reactive protein for detection of early infections after lumbar microdiscectomy.

Authors:  B Meyer; K Schaller; V Rohde; W Hassler
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 7.  Pentraxins in the activation and regulation of innate immunity.

Authors:  Kenji Daigo; Antonio Inforzato; Isabella Barajon; Cecilia Garlanda; Barbara Bottazzi; Seppo Meri; Alberto Mantovani
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

8.  CRP-Guided Antibiotic Therapy for Acute COPD Exacerbation: a Randomized Control Trial.

Authors:  Jocelyn A Carter; Harry B Burke
Journal:  J Gen Intern Med       Date:  2021-05-04       Impact factor: 6.473

9.  The occurrence during acute infections of a protein not normally present in the blood. V. Physical-chemical properties of the C-reactive protein crystallized by a modified technique.

Authors:  H F WOOD; M McCARTY; R J SLATER
Journal:  J Exp Med       Date:  1954-07-01       Impact factor: 14.307

10.  Kitasato symposium 2009: new prospects for cytokine inhibition.

Authors:  Gerd R Burmester; Peter E Lipsky; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2009-12-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.